Friday, September 3, 2021

Indian doctors go to US for money.not enough doctors in villages

fake doctors' held after raids on illegal clinics in Shivaji Nagar

https://indianexpress.com › Cities › Mumbai


Patient dies after fake doctor performs surgery at Pakistan ...

07-Jun-2021 — Authorities in Pakistan have charged a former security guard with impersonating a doctor at a hospital in Lahore, after he allegedly ...

Mother & Newborn Die After Fake Doctor Uses Shaving Blade ...

sw-ke.facebook.com › videos
The owner of the Maa Sharda Hospital, Rajesh Sahni, had reportedly employed 30-year-old Rajendra Shukla, a ...
20-Mar-2021

Fake doctor arrested from AIIMS Delhi - YouTube

www.youtube.com › watch
Fake doctor arrested from AIIMS DelhiFor latest breaking news, other top stories log on to: http://www.abplive ...
04-Feb-2017 · Uploaded by ABP NEWS

Fake Doctors, Negligent Administration Lead to 33 HIV+ ...

www.thequint.com › videos › news-videos › unnao-up-q...
Fake Doctors, Negligent Administration Lead to 33 HIV+ Cases in UP. The residents are requesting the ...
11-Feb-2018 · Uploaded by The Quint

Hyderabad: Fake doctor arrested at Osmania general hospital

https://www.siasat.com › Hyderabad News
26-Aug-2021 — The police arrested the fake doctor and identified him as Marwan bin Abdul Aziz al-Saud (27) of Chandrayangutta, Bandlaguda area. Doctors said ...
11-Jun-2021 — Nagpur: Casualty Medical Officer (CMO) nabbed a fake doc tor who was posing as resi dent doctor of medicine department in Government Medical ...
03-Jun-2021 — Simon Nag, 37, a resident of Balijan under Chabua police station, had been impersonating one Dr Stephen Anthony since 2009 to get a job at ...
Get all the latest news and updates on Fake Doctors only on News18.com. Read all news including political news, current affairs and news headlines online on ...
14-Aug-2021 — Continuing with its action against the fake doctor, cops — acting on a tip-off received by Bharuch SP Rajendrasinh Chudasama — conducted ...
Masterminds behind fake insurance racket nabbed in Kalyan. The accused Chandrakant Shinde, along with two doctors from Mumbra and a TMC employee was arrested by ...
09-Feb-2021 — Fake doctor nabbed ... Mangum Kiran Kumar, 48, of Bheemili in Visakhapatnam, practised as a medical doctor at different hospitals at Rajam, ...
17-Jun-2021 — According to reports, Majuli police arrested a fake doctor who had been treating patients for the past 25 years on Wednesday night.
dental clinic or the name of the fake doctor allegedly practising for the past seven years. PW1, while ... order to find that the petitioner was a fake ...

Chhattisgarh Fake Doctor: छत्‍तीसगढ़ में फर्जी दस्तावेजों के सहारे ...

https://www.naidunia.com › ... › raipur
4 days ago — Chhattisgarh Fake Doctor: छत्तीसगढ़ में 1616 बाहरी आयुर्वेद डाक्टरों ने कराया है पंजीयन ...
31-May-2021 — Rachakonda Police Commissioner Mahesh Bhagwat on Monday issued orders under the Preventive Detention Act against P Sai Kumar, a fake doctor.
25-Nov-2017 — Rajahmundry: Vigilance and enforcement sleuths have exposed several fake doctors who are running super specialty hospitals and clinics by ...
The CID has identified over 500 fake doctors practising in government hospitals and private clinics in West Bengal.
07-Jun-2017 · Uploaded by Zee News

Indian fake doctor injects 21 with HIV through tainted syringes

www.usatoday.com › story › news › world › 2018/02/06
LUCKNOW, India – A fake doctor treating poor villagers in northern India for colds, coughs and diarrhea has ...
06-Feb-2018

Fake doctor nabbed in Jamnagar | TV9News - YouTube

Fake doctor nabbed in Jamnagar | TV9News | D51#Jamnagar #GujaratiNews #TV9News Tv9 ગુજરાતીની ...
14-Mar-2021 · Uploaded by TV9 Gujarati

Fake' doctor accused of infecting 46 Indians with HIV arrested

www.straitstimes.com › asia › south-asia › fake-doctor-ac...
NEW DELHI (AFP) - Indian police on Wednesday (Feb 7) arrested an unlicensed doctor accused of infecting ...
07-Feb-2018 · Uploaded by The Straits Times

fake doctor Ajay tiwari arrested - YouTube

fake doctor Ajay tiwari arrested. 5,837 views5.8K views. Jun 4, 2017. 15. 2. Share. Save. 15 / 2. ABP ANANDA ...
04-Jun-2017 · Uploaded by ABP ANANDA

UP's Vyapam scam: 600 fake doctors busted - The Times of ...

timesofindia.indiatimes.com › City News › meerut News
MEERUT: In a major breakthrough in what is now being dubbed as 'Uttar Pradesh's own Vyapam scam ...
21-Mar-2018

Pune,Shirur Fake Doctors Treatment On Corona ... - YouTube

www.youtube.com › watch
Pune,Shirur Fake Doctors Treatment On Corona Patients Update. 13K views · 4 months ago. 104. Dislike. Share ...
12-Apr-2021 · Uploaded by Zee 24 Taas

Fake doctor busted in Siliguri, shocking inputs revealed after ...

Fake doctor busted in Siliguri, shocking inputs revealed after arrest. Siliguri Times was live. March 23 ·. Fake ...
23-Mar-2021

earch on for fake doctor in Dibrugarh - Sentinelassam

Police have identified another fake doctor working in the Moncotta Tea Estate as an imposter of Professor of ...
19-Jun-2021 · Uploaded by The Sentinel
পুলিশের জালে ভুয়ো ডাক্তার। ঘটনার তদন্তে নেমেছে পুলিশ।
24-Jul-2021

TV9 exposes hundreds of fake doctors - TV9 - YouTube

TV9 exposes hundreds of fake doctors - TV9Watch iSmart News latest episode: ...
12-Dec-2020 · Uploaded by TV9 Telugu Live


Exclusive: Delhi's fake doctors exposed - YouTube

www.youtube.com › watch
Delhi has more than 40000 fake doctors who are running their clinics in spite of show cause notices and ...
19-Jul-2014 · Uploaded by Zee News


Govt had trashed WHO report pointing 57% doctors in India ...

www.gaonconnection.com › Read
Its owner, a self-proclaimed doctor, told Gaon Connection over phone: "I ... "Many lives are lost at the hands of ...
22-Aug-2019 · Uploaded by Gaon Connection TV



Govt had trashed WHO report pointing 57% doctors in India are fake.
Health ministry now says it's true

The World Health Organization had informed in its report of 2016 that
57.3% of doctors in India are in fact quacks -- they operate without a
medical degree. The then Union Health Minister JP Nadda was quick in
dissing the report as erroneous, but now Union Health Ministry is
admitting it to be true. And, it’s not surprising that most of them are
found in rural pockets of the country



A shanty beside the road, bottles of pills upon a small desk and a
banner of Mr Doctor festooned above gives a fair picture of rural health
 services in India. The clinic is a sure indication of its owner's
degrees and abilities. The government too has admitted that out of the
total number of allopathic doctors in India, 57.3% are quacks and so
practice without a degree.

A Bengali dawakhana (clinic) operating in Zalim Nagar, Behraich keeps
medicines of all sorts. Its owner, a self-proclaimed doctor, told Gaon
Connection over phone: "I treat minor ailments and give only those
medicines which do not affect the patient adversely. I have to shell out
 a fixed monthly amount to the health department people in order to
operate my clinic. I may be called a quack, but it is also a fact that
without people like me many will perish for lack of medical care. The
reality of government hospitals and doctors is open to all."

The World Health Organization in its 2016 report had informed that about
 57.3% of the doctors practicing in India are quacks and have not
undergone any medical education. Erstwhile Union Health Minister JP
Nadda had put down the report as erroneous, but now the Health Ministry
is admitting it to be true.

One may be able to explain the deluge of quack in the country especially
 its rural region. Requesting anonymity one such doctor revealed: "I was
 a science student till 12th. Due to economic reasons I could not finish
 my education and took up a job in a medical store in town. Slowly I
gained the knowledge of various medicines and learnt to use a syringe.
After sometime I opened up a medical store in the village, here people
come to me in routine illness. They get cheap treatment and I my daily
earnings of 4-5 hundred rupees. I even do farming when time permits."


Quacks such as these can easily be found in every village and town
because of our ailing government health services system. As per National
 Rural Health Mission (NRHM), Uttar Pradesh has only 3,692 primary
health centres (PHCs) as against the required number of 5,172. The
condition of the existing PHCs is another matter of concern.

Indian Medical Association (IMA) Lucknow's president Dr GPSingh told
Gaon Connection: "Many lives are lost at the hands of quacks and fake
doctors. It is been often observed that people prefer being treated by
quacks as it saves them time and money." He added, "few people work as
compounders with doctors for a couple of years and thereafter set up
their own clinics with no degree and experience of a doctor. Such person
 may not even know how to give injections. The government policy and
public both are to be blamed for mushrooming of such malpractices."

As per a report of India Spend, Uttar Pradesh had witnessed a fall in
the number of PHCs by 8% in past 15 years while its population has
increased by 25%. From past 25 years till 2015 small sub centres (first
point of contact with public) have not seen an increase of more than 2%.
 As per Ministry of Health and Family Welfare, India has 1,23,655 health
 sub centres, 25,308 primary health centres, 5,396 community health
centres, 779 district hospitals and 1,108 sub divisional hospitals.
Neelesh Misra

Delhi High Court's senior advocate and working for Right to Public
Health, Ashok Agarwal,said: "India has neither the adequate number of
hospitals nor doctors. There is a huge gap in the quality of healthcare
facility as well as its availability. The gap exists not only within
states, but also between rural and urbanregions. Due to unavailability
of government doctors, public is forced to seek medical help from the
fake ones as the only alternative."

Working in the field of health services an NGO Jan Swasthya Abhiyan's
National Coordinator-Sulakshna Nandi told Gaon Connection over phone,
"Our country's public health system has totally gone kaput.The country's
 primary health is itself ailing especially in rural areas. No MBBS
doctor wants to go to a village so a large portion of Indian population
is left at the mercy of quacks. Sometimes misdiagnosis even takes away
life of hapless people whohave but little choice. The government needs
to first pull up its primary health care services."


As per report issued by the Union Ministry of Health's Central Bureau of
 Health Intelligence, in India there is only 1 doctor per 11082 citizens
 whereas it should be a doctor per thousand as per set standards. This
ratio is 11 times less than the set standard parameters. Bihar presents
even scarier scenario with 1 doctor per 28391 citizens. Uttar Pradesh,
Jharkhand, Madhya Pradesh, Chhattisgarh too face a grim situation.

Often in desperation and in lure of cheap treatment people, resorting to
 doctors without degree, put their lives to risk. "I suffered from
piles. Despite showing to the doctors I could not find a relief. Then
one of my relatives told me about a doctor in town who claimed
guaranteed treatment. When I approached him his clinic boldly flashed
his so called 'MBBS' degree," said Manoj Mishra, 38 years from
Gorakhpur.

He added: "Initially he put me on some medication for two months but to
little effect. He then broached the topic of operation. My condition
aggravated after the operation-the operated spot became infected and
started oozing pus. With my condition turning critical I was taken to a
big hospital in Delhi for treatment where it was told that the operation
 was not done properly leading to infection. Had there been any further
delay the spot may even have turned cancerous."

At the same time a quack puts the blame on the system, "The country has
several fake institutes handing out innumerable fake medical degrees
each year. Any untoward incident happens, the government penalizes us
and embarks on a tirade against us, but no one acts against those
fictitious institutions. It is because they have vested interests."

The Delhi High Court's advocate, Ashok Agarwal,said: "We have strict
laws against quacks. If an untrained or unqualified person treats a
patient, he can be severely penalized for fraud under Section 419,420
besides Indian Medical Council Act's Section 15 (3). This Act provides
for upto 2 years of imprisonment. For holding a fake degree, one could
be prosecuted under Section 468, 47.

Gaon Connection

   

Fake Doctor Busted At Meerpet Hyderabad | NTV - YouTube

నగరంలో నకిలీ డాక్టర్..! | Fake Doctor Busted At Meerpet Hyderabad | NTV. 18,318 views18K views. Dec 11, 2020.
12-Dec-2020 · Uploaded by NTV Telugu

Fake doctor named Naren Pandey busted from his clinic at ...

www.youtube.com › watch
Fake doctor named Naren Pandey busted from his clinic at North Kolkata.To satisfy the demands of high-rise ...
29-May-2017 · Uploaded by Zee 24 Ghanta

Fake Doctor Caught In #PublicTV Sting Operation - YouTube

www.youtube.com › watch
PublicTV has caught a fake doctor red handed in Kurubarahalli, Bengaluru. Krishna who claims himself as a ...
29-Aug-2018 · Uploaded by Public TV | ಪಬ್ಲಿಕ್ ಟಿವಿ

Assam: Another Fake Doctor Arrested in Sonari, Sivasagar

www.sentinelassam.com › NE News › Assam News
At a time when Assam, like the rest of the country, is suffering from the demonic grasp of the COVID-19 ...
30-Jul-2021 · Uploaded by The Sentinel

an elder man who was treated by a fake doctor dies - Tamil ...

tamil.samayam.com › ... › viluppuram
திண்டிவனம் அருகே உடல்நிலை சரியில்லாத நிலையில் போலி மருத்துவரிடம் ...
10-Jul-2021

Fake doctor held in Tirupati : ఫేక్ డాక్టర్ పై విచారణ - TV9

www.youtube.com › watch
Fake doctor held in Tirupati : ఫేక్ డాక్టర్ పై విచారణ - TV9. 1,834 views1.8K views. Jul 3, 2021.
03-Jul-2021 · Uploaded by TV9 Telugu Live

Fake #doctor arrested from #GMC #Jammu, #Ambulance ...

Fake #doctor arrested from #GMC #Jammu, #Ambulance #sealed.
17-Jun-2021

Wednesday, September 1, 2021

investigations of close relationship between Biogen and the FDA

 

Neurology | Opinion

Alzheimer’s, Inc.: When a Hypothesis Becomes Too Big to Fail

This summer’s controversy surrounding the FDA’s shocking approval of the drug aducanumab provides a window into a scientific field in crisis

Credit: Getty Images

Aducanumab, marketed as “Aduhelm,” is an antiamyloid monoclonal antibody and the latest in a procession of such drugs to be tested against Alzheimer’s disease. Over the last several decades, billions have been spent targeting the amyloid that clumps together to form the neuritic plaques first documented by German psychiatrist Alois Alzheimer in 1906. This class of drugs has reduced amyloid aggregation; however, since 2000, there has been a virtual 100 percent fail rate in clinical trials, with some therapies actually worsening patient outcomes.

In 2019, Aducanumab failed in a futility analysis of two pooled phase III randomized controlled trials, but was later claimed to have yielded a small benefit for a subset of patients in a high-dosage group. The biologic was granted accelerated approval by the FDA based not on its clinical benefit but rather on its ability to lower amyloid on PET scans. Biogen immediately priced the treatment at $56,000 annually, making it potentially one of the most expensive drugs in the country’s history.  

This predicament is all the more surreal because—in the absence of more decisive evidence—there is no adequate proof that the drug actually clinically benefits people who take it. Aducanumab, which is delivered intravenously, was observed to cause brain swelling or bleeding in 40 percent of high-dose participants as well as higher rates of headache, falls and diarrhea. The FDA’s decision flew in the face of a near-consensus recommendation from its advisory committee not to approve. Three members of that committee have since resigned; several federal investigations have been launched to examine the close relationship between Biogen and the FDA; and the Department of Veterans Affairs and numerous private insurers and high-profile hospital systems have already signaled they want nothing to do with the drug. Meanwhile, Biogen has launched a Web site and comprehensive marketing campaign called “It’s Time,” quizzing potential consumers on their memory loss and ultimately guiding them to experts, imaging and/or infusion sites.  

The aducanumab debacle is a microcosm of how the medical-industrial complex has taken hold within the Alzheimer’s field for decades, distorting science and policy while limiting other promising avenues of research and action on brain health and the care of persons living with dementia. 

At the heart of this problem is that the field has ossified in decidedly unscientific fashion around the amyloid cascade hypothesis—i.e., the belief that amyloid is toxic and initiates processes disrupting cell function. This has funneled federal, foundation and pharmaceutical/venture capital funding disproportionately into amyloid research despite the fact that the protein’s causal role remains unclear. Indeed, up to 40 percent of people in their 70s have amyloid deposits but normal cognition. It remains a possibility that amyloid deposits are not themselves causal but rather are part of the brain’s injury response.  

Moreover, despite its singular label, “Alzheimer’s” is increasingly understood as a heterogeneous syndrome involving not merely the hallmark amyloid plaques and tau tangles, but other features such as vascular changes. A majority of clinical “Alzheimer’s” cases are, in fact, actually observed to be mixed dementias. It is perhaps unsurprising that “attacking” one aspect of that syndrome (amyloid) has not “cured” Alzheimer’s; however, it is surprising to witness the field’s inability to modify or abandon the amyloid hypothesis in light of contravening evidence. Such is the stultifying effect of the medical-industrial complex, which has aligned incentives with fame and fortune based on the pursuit of single-mechanism drugs rather than the clear-eyed scrutiny demanded by the scientific method.  

Constituted in this narrow fashion, the gatekeepers controlling the field’s agenda—what some have referred to as the “Alzheimer’s cabal”—have exerted strong downwards pressure to endorse the amyloid hypothesis. Journals, conferences and professional societies promote and reward research endorsing the conventionally accepted premises. Careers are built and consulting opportunities gained by amassing publications and funding based on received wisdom. Meanwhile, those challenging the dominant agenda have been marginalized, with funding flowing away from other plausible theories of causation. To question whether it is even reasonable to expect biotechnology to cure a condition as complex and intimately age-related as Alzheimer’s syndrome has been treated as heresy.   

The reductive molecular, industry-driven approach has also narrowed imaginative thinking about how to adapt to the challenges we face as an aging society. As we write in our forthcoming book American Dementia (Johns Hopkins University Press, 2021), one of the most compelling recent research findings is that dementia rates have been in decline in the U.S., Canada, the United Kingdom, France, Sweden and the Netherlands over the past decade.

This trend has little to do with biotechnology, and much to do with mid-20th-century public policy that increased total years of education for those now in their retirement years (via the G.I. Bill and investment in state colleges and universities in the U.S.), expanded health care and improved treatment of risk factors that affect the brain (i.e., vascular disease, high-cholesterol), remarkably successful smoking cessation programs, and deleading gasoline. In combination, these state actions in service of public health are believed by most experts—including the Lancet Commission on dementia prevention—to have enhanced the cognitive reserve of today’s older adults.  

A field not captured by industry might ask whether 21st-century governments are capable of engendering such population-level actions focused on improving larger institutions, structures and social processes that benefit brain health. Arguably, achieving universal health care and higher education and addressing the nation’s aging water pipe infrastructure (which has yielded a modern-day lead crisis) could be expected to make similar contributions to brain health across decades. So too would provision of long-term care insurance provide material security for elders who currently live in a precarious situation wherein the U.S. government won’t pay for care through Medicaid until they spend down essentially all their assets.

Moreover, we have observed in our combined seven decades of work the profound effects of the arts in dementia-care environments. Music, dance, storytelling, expressive artwork, gardening, intergenerational activities, pet therapy and other creative, relationship-oriented approaches that tap into quintessential elements of our humanity improve quality of life for elders and their caregivers far more than current drugs, including aducanumab. These “socialceuticals” deserve our investment even if they are not commodities that will ultimately generate revenue for industry.

Ultimately, aducanumab reflects the forces that have led the Alzheimer’s field astray in the 21st century. When industry drives research incentives, and when a hypothesis becomes “too big to fail” we squander scarce resources, lose precious time, and fail to properly adapt to one of the major challenges of our era.  

This is an opinion and analysis article; the views expressed by the author or authors are not necessarily those of Scientific American.

Rights & Permissions


==========================================

Verified by Psychology Today

About

Daniel R. George, Ph.D., M.Sc., is an associate professor of Humanities and Public Health Sciences at Penn State College of Medicine. He earned his Ph.D. and M.Sc. in medical anthropology from Oxford University in 2010. George is the co-author of The Myth of Alzheimer’s, (St. Martin’s Press, 2008) the co-author of American Dementia (Johns Hopkins University Press, 2021). He has over 130 professional peer-review publications, and his research on intergenerational issues in dementia care has been recognized by the global advocacy group Alzheimer’s Disease International.

Sunday, July 4, 2021

Using Artificial Intelligence (AI) for developing a system to detect genital skin cancer

 Two teenagers from the city — Sidharth Jain and Aasimm Khan — have won the prestigious Microsoft Imagine Cup award in the junior category of World Solutions Using Artificial Intelligence (AI) for developing a system to detect genital skin cancer.2 days ago

 
Feedback

Top stories

Mumbai teens bag award for AI-based system to detect skin cancer ... The 17-​year-olds, who have received the Microsoft Imagine Cup award, have applied to​ ...


Wednesday, June 23, 2021

Genetic diseases being solved by quantitative biologists

 

Genetic diseases that puzzle lab scientists are being solved by quantitative biologists. ... The boy was only a month old but had developed the amount of health problems that other people don't acquire in a lifetime. ... There were supportive treatments for CGD, but ones that worked for some patients didn't necessarily work ...
Biology | Genetics · Data Crunchers to the Rescue. Genetic diseases that puzzle lab scientists are being solved by quantitative biologists. From Issue 102 Chapter One ... The boy was only a month old but had developed the amount of health problems that other people don't acquire in a lifetime. He was constantly suffering​ ...

Wednesday, May 12, 2021

 

The Statistical Secrets of Covid-19 Vaccines | WIRED

6 days ago — They're really very good, and they're the only way out of the pandemic. But a tour through the numbers could bring the vaccine-hesitant into the ...

wired.com

The Statistical Secrets of Covid-19 Vaccines

They’re really very good, and they’re the only way out of the pandemic. But a tour through the numbers could bring the vaccine-hesitant into the tent.

Friday, May 7, 2021

Synthetic T Cells the Next Big Thing in Immunotherapy ...(AND COVID)

 

JUN 28, 2018 11:07 AM PDT

Synthetic T Cells the Next Big Thing in Immunotherapy[AND COVID]

WRITTEN BY: Kara Marker

The highly complex structure and function of human T cells made the creation of synthetic versions of the immune cells difficult, but scientists from the University of California – Los Angeles (UCLA) have finally done it. In their new study, researchers discuss the journey of developing nearly perfect copies of human T cells.

T cells, or T lymphocytes, are white blood cells that develop from stem cells in the bone marrow and mature in the thymus. They are activated as part of the adaptive immune response when the body is under attack from some sort of bacterial or viral infection. T cells also work with B cells to fight cancer and produce antibodies specific to incoming pathogens.

T cell receptors allow T cells to recognize foreign particles (antigens). Two main types of T cells, cytotoxic and helper T cells, perform all of the different functions required by the adaptive immune system to respond to a variety of different attacks on the body. Uniquely, T cells can shrink to as much as 25 percent of their normal size to fit between small gaps and pores or grow to three times their normal size to fight pathogenic foes.

"The complex structure of T cells and their multifunctional nature have made it difficult for scientists to replicate them in the lab," explained study leader Dr. Alireza Moshaverinia. "With this breakthrough, we can use synthetic T cells to engineer more efficient drug carriers and understand the behavior of immune cells."

UCLA researchers had to first deal with several obstacles before they could successfully create a true synthetic T cell. T cells are delicate, surviving for only a few days after extraction from humans or animals. T cells also have complex shape, size, and flexibility qualities. Matching these qualities exactly is vital for T cells to function on a basic level during infection.

After overcoming these obstacles, researchers moved on to a series of technologies to produce their synthetic T cells. First, they used a microfluidic system to combine two different fluid solutions that created microparticles of alginate. These microparticles can then be used to duplicate the form and structure of natural human T cells.

To attain the right level of flexibility, researchers made adjustments via changing concentrations of calcium ions in a “calcium ion bath.” They covered T cells with phospholipids to mirror the image of human cellular membranes. Lastly, they used a “bioconjugation” process to link synthetic T cells with their own surface receptors that are required for activation during the adaptive immune response.

"We were able to create a novel class of artificial T cells that are capable of boosting a host's immune system by actively interacting with immune cells through direct contact, activation or releasing inflammatory or regulatory signals," explained UCLA’s Mohammad Mahdi Hasani-Sadrabadi. "We see this study's findings as another tool to attack cancer cells and other carcinogens."

A great part of this process is that researchers predict that it can also be used to create all kinds of artificial immune cells. With synthetic T cells, researchers can develop new drugs to treat cancer, autoimmune disease, and immune deficiency. Plus, scientists can have a unique new way to study the biology of the human immune system.

The present study was published in the journal Advanced Materials.

Sources: PubMed Health, British Society for Immunology, University of California – Los Angeles

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.

"MUMBAI MODEL" OF OXYGEN MANAGEMENT A SUCCESS

 

Top stories


How Mumbai got breather: Year before 2nd wave, BMC set up oxygen team

5
FacebookTwitterLinkedinEMail
AA
Text Size
  • Small
  • Medium
  • Large
Oxygen cylinders at the Covid unit at the erstwhile Mulund octroi naka
By: P Velrasu
Much interest has been generated on the ‘Mumbai Model’ of oxygen management after recent observations by the Supreme Court. I wonder what could make a management method unique and get its own name when the ingredients at hand seem to be common among cities. The success of the Mumbai Model can be attributed to centralization of certain aspects and decentralization of the services aspect.
Understanding the requirements for Mumbai and micro-planning was essential for successful oxygen management in this mega city. Efficiently doing so in a pandemic involves many aspects, including resource and inventory mapping, generating storage capacities, and proper supply chain management.
The BMC started with resource mapping and inventory accounting in May 2020 following oxygen difficulties in one of our hospitals within three months of the Covid outbreak in Mumbai. Our ‘Oxygen Team’ was asked to visit every hospital and compile data on storage capacity, supply method, suppliers’ names and supply periodicity. We accounted for much increased oxygen demand during the pandemic and expected the number of ICU and oxygenated beds to go up.
The next step was to increase storage capacities by installing additional cryogenic tankers in civic hospitals. The work was completed within 40 days. Underutilized during the first Covid wave, the tanks took the load during the second Covid wave very effectively.
Adequate supply of liquid medical oxygen is of paramount importance. I think this is where Delhi has faced problems. The basic supply quantity has to be sufficient even if everything else is in place. On three consecutive days Mumbai too witnessed lots of SOS calls. We shifted many patients to bigger hospitals without any casualty. Excellent teamwork was put forth by the BMC.
Fortunately for Mumbai, there is an oxygen team at work round the clock in Mantralaya too. There are at least five IAS officers who work round the clock to secure increased supplies of liquid medical oxygen from new sources. Once our supply inadequacy was flagged at that level, Mumbai was allotted 30 metric tonnes from a steel plant in Raigad. Also, later supplies were augmented with tankers from Jamnagar. Had these additional supplies not been ensured in time, Mumbai too would have had problems. No amount of good management can compensate for supply inadequacies — simple and straight.
Again, proper supply chain management is critical to avoid any supply disruptions. Because new difficulties can emerge any time: oxygen filling stations at manufacturing plants are lined with tankers and waiting times have become longer because now the plants are supplying real-time.
When in an emergency, contacting a plant and requesting for an out-of-turn filling also helps, an option we have exercised sometimes! A point to remember is that optimising the turnover time is crucial since the number of cryotankers is limited.
Currently, the oxygen team is working on future-proofing Mumbai from the shocks and exigencies of oxygen supply. We will be installing self-generating oxygen plants in all BMC hospitals as augmentation measures. The new plants will be able to cater to 100% of patients in normal times and during extreme situations too. This supply system will work well without stress even during disruptions.
(The author is additional municipal commissioner — projects — BMC. As told to Chaitanya Marpakwar)
FacebookTwitterLinkedinEMail
Latest Comment
M
Maha For Marathis
3 minutes ago
Maha greatest positive contributor and God's gift to India. Jai Maha
Add commentread Comments